Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group.

Pollack IF, Hamilton RL, Sobol RW, Nikiforova MN, Lyons-Weiler MA, LaFramboise WA, Burger PC, Brat DJ, Rosenblum MK, Holmes EJ, Zhou T, Jakacki RI; Children's Oncology Group.

Childs Nerv Syst. 2011 Jan;27(1):87-94. doi: 10.1007/s00381-010-1264-1. Epub 2010 Aug 20.

2.

IDH1 and IDH2 mutations in gliomas.

Cohen AL, Holmen SL, Colman H.

Curr Neurol Neurosci Rep. 2013 May;13(5):345. doi: 10.1007/s11910-013-0345-4. Review.

3.

Molecular pathogenesis of IDH mutations in gliomas.

Ichimura K.

Brain Tumor Pathol. 2012 Jul;29(3):131-9. doi: 10.1007/s10014-012-0090-4. Epub 2012 Mar 8. Review.

PMID:
22399191
4.

An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy.

Yang Y, Mao Q, Wang X, Liu Y, Mao Y, Zhou Q, Luo J.

J Clin Neurosci. 2016 Sep;31:56-62. doi: 10.1016/j.jocn.2015.11.030. Epub 2016 Jul 9. Review.

PMID:
27406953
5.

[IDH1/2 mutations in gliomas].

Nobusawa S, Yokoo H.

Brain Nerve. 2011 Dec;63(12):1378-86. Review. Japanese.

PMID:
22147457
6.

IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma.

Zhang C, Moore LM, Li X, Yung WK, Zhang W.

Neuro Oncol. 2013 Sep;15(9):1114-26. doi: 10.1093/neuonc/not087. Epub 2013 Jul 21. Review.

7.

Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?

Kloosterhof NK, Bralten LB, Dubbink HJ, French PJ, van den Bent MJ.

Lancet Oncol. 2011 Jan;12(1):83-91. doi: 10.1016/S1470-2045(10)70053-X. Epub 2010 Jul 7. Review.

PMID:
20615753
8.

Isocitrate dehydrogenase mutations: a challenge to traditional views on the genesis and malignant progression of gliomas.

Weller M, Wick W, von Deimling A.

Glia. 2011 Aug;59(8):1200-4. doi: 10.1002/glia.21130. Epub 2011 Feb 3. Review.

PMID:
21294161
9.

Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management.

Taylor JW, Chi AS, Cahill DP.

Oncology (Williston Park). 2013 Jun;27(6):504-14. Review.

10.

IDH1 mutations in gliomas: first series from a tertiary care centre in India with comprehensive review of literature.

Jha P, Suri V, Sharma V, Singh G, Sharma MC, Pathak P, Chosdol K, Jha P, Suri A, Mahapatra AK, Kale SS, Sarkar C.

Exp Mol Pathol. 2011 Aug;91(1):385-93. doi: 10.1016/j.yexmp.2011.04.017. Epub 2011 May 3. Review.

PMID:
21569770
11.

Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.

Chen R, Ravindra VM, Cohen AL, Jensen RL, Salzman KL, Prescot AP, Colman H.

Neurosurg Focus. 2015 Mar;38(3):E2. doi: 10.3171/2015.1.FOCUS14745. Review.

PMID:
25727224
12.

Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications.

Gupta R, Webb-Myers R, Flanagan S, Buckland ME.

J Clin Pathol. 2011 Oct;64(10):835-44. doi: 10.1136/jclinpath-2011-200227. Epub 2011 Jul 12. Review.

PMID:
21752797
13.

Mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 in tumors.

Schaap FG, French PJ, Bovée JV.

Adv Anat Pathol. 2013 Jan;20(1):32-8. doi: 10.1097/PAP.0b013e31827b654d. Review.

PMID:
23232569
14.

IDH mutations may not preclude distant, trans-tentorial spread in gliomas: a case report and review of the literature.

Hong CS, Hsieh JK, Edwards NA, Ray-Chaudhury A, Zaghloul KA.

World J Surg Oncol. 2016 Feb 24;14:53. doi: 10.1186/s12957-016-0814-8. Review.

15.

Isocitrate dehydrogenase 1 and 2 mutations in gliomas.

Megova M, Drabek J, Koudelakova V, Trojanec R, Kalita O, Hajduch M.

J Neurosci Res. 2014 Dec;92(12):1611-20. doi: 10.1002/jnr.23456. Epub 2014 Jul 31. Review.

PMID:
25078896
16.

Analysis of isocitrate dehydrogenase-1/2 gene mutations in gliomas.

Yu L, Qi ST, Li ZY.

Chin Med J (Engl). 2010 Dec;123(24):3697-705. Review.

PMID:
22166653
17.

IDH mutations in human glioma.

Kim W, Liau LM.

Neurosurg Clin N Am. 2012 Jul;23(3):471-80. doi: 10.1016/j.nec.2012.04.009. Epub 2012 May 31. Review.

18.

Advances in genetic and epigenetic analyses of gliomas: a neuropathological perspective.

Tsankova NM, Canoll P.

J Neurooncol. 2014 Sep;119(3):481-90. doi: 10.1007/s11060-014-1499-x. Epub 2014 Jun 25. Review.

PMID:
24962200
19.

Pediatric gliomas as neurodevelopmental disorders.

Baker SJ, Ellison DW, Gutmann DH.

Glia. 2016 Jun;64(6):879-95. doi: 10.1002/glia.22945. Epub 2015 Dec 6. Review.

20.

Gliomas Genomics and Epigenomics: Arriving at the Start and Knowing It for the First Time.

Filbin MG, Suvà ML.

Annu Rev Pathol. 2016 May 23;11:497-521. doi: 10.1146/annurev-pathol-012615-044208. Epub 2016 Mar 2. Review.

PMID:
26980161

Supplemental Content

Support Center